Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome

Clinical trial NCT07168434 · RECRUITING

Trial details

NCT number: NCT07168434
Sponsor: Biocodex
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

IBS (Irritable Bowel Syndrome)IBS-D (Diarrhea-predominant)IBS, Mixed Symptoms

Start date: 2025-10-22
Primary completion: 2026-10-11
Enrollment: 406

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.